Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Blood test

Estradiol Blood Test: Results, Cycle Timing, and Menopause

An estradiol result only makes sense with the reason for testing. The same value can mean something different during puberty, across the menstrual cycle, after menopause, in a man, or during hormone or fertility treatment. Keep the timing, lab method, medicines, and related hormone results with it.

Measures Estradiol in one serum sample Interpret with Question, cycle day, medicines, and method Low values LC-MS/MS may be the better method What to record A short symptom and timing record
01

What an estradiol result can show

Estradiol changes during the menstrual cycle and may be hard to measure at low levels. The same result can mean different things based on cycle day, bleeding, pregnancy, hormone medicines, FSH, LH, and the lab method. It does not show how much estradiol is acting in the brain.

When it helps

It supports a defined workup

Estradiol can help answer questions about puberty, missing periods, ovarian function, fertility treatment, breast growth in men, and treatment follow-up.

Timing

Cycle day can change the result

Estradiol rises and falls during a natural cycle. One random result may not show where you are in that cycle.

Method

Low values need enough sensitivity

Near its lower limit, an immunoassay may be less useful than LC-MS/MS for children, men, and women after menopause.

Limit

It does not measure estradiol in the brain

One blood result can't diagnose brain fog, PMDD, fertility, or future thinking problems. Most women over 45 do not need it to diagnose menopause.

Do not let one number become the diagnosis

Read estradiol with the reason for testing and the person's cycle or life stage. Pregnancy possibility, hormone products, test method, units, lab range, FSH, LH, and symptoms also matter.

Save this test

Save the timing and method with the value

Keep the result with the reason for testing, cycle or life-stage timing, hormone products, method, related results, symptoms, and the plan.

If a repeat is planned, save the exact timing, method, and decision it should help make.

02

What can change an estradiol result

Estradiol changes with age, puberty, cycle day, pregnancy, medicines, ovarian function, and sex. The lab method makes the biggest difference at low expected levels.

Children and teenagers

Puberty stage, growth, the exam, LH, FSH, and bone age usually matter more than one E2 result. Ask for a child-specific range and a sensitive method when the level may be low.

Cycling women

Cycle day, bleeding, possible pregnancy, birth control, and the reason for testing change the meaning. A result expected early in the cycle may not answer a question about ovulation later in the month.

Pregnancy, postpartum, and breastfeeding

Pregnancy changes estradiol, but this is not a pregnancy test. Use hCG and maternity care for pregnancy questions. After birth, also record bleeding, pain, feeding, sleep, medicines, anemia, and thyroid results.

Women with menopause symptoms

From age 45, symptoms and period history usually show menopause better than a random hormone test. Testing may help when changes start younger, periods stop without a clear reason, or another hormone problem is possible.

Men

Estradiol may be checked for breast growth, infertility, puberty, testicle, adrenal, liver, body-weight, or treatment questions. At low levels, use a sensitive method and read it with testosterone, SHBG, LH, FSH, medicines, and the exam.

Older adults and people using hormone or cancer treatment

The treatment, how it's taken, time of the last dose, cancer history, body composition, and lab method all matter. Fulvestrant can affect some immunoassays, so Mayo uses mass spectrometry for these patients.

03

How to prepare for the blood test

Ask what question the test should answer. It may be about puberty, missing periods, ovarian function, fertility care, menopause before age 45, breast growth in men, or treatment follow-up.

Record the first day of your last period, usual cycle length, current bleeding, possible pregnancy, postpartum or breastfeeding status, and the draw date and time. Follow the clinic's exact cycle-day plan for fertility care.

List birth control, fertility drugs, estrogen, progesterone, testosterone, DHEA, aromatase inhibitors, fulvestrant, creams, patches, pellets, injections, and supplements. Keep taking medicine unless your prescriber tells you to stop.

Estradiol itself usually needs no special diet. Ask whether other tests require fasting. Follow the lab's biotin rule because biotin can affect some methods. Mayo's rapid test asks you to stop biotin supplements for 12 hours before the draw.

01

Name the question

Ask what decision this result should change. That tells you whether one test, a timed test, or several tests are useful.

02

Record the collection timing

Save the date, time, cycle day, bleeding dates, pregnancy details, and any timing rule from the fertility clinic.

03

Keep the method and units

Save the value, pg/mL or pmol/L unit, lab range, test method, detection limit, and any note about interference.

04

Read the nearby results

Read estradiol with FSH, LH, hCG, prolactin, TSH, symptoms, exam findings, or an ultrasound when those are part of the workup.

05

Decide what happens next

Ask whether the result answers the question, needs a more sensitive test, or suggests a different check.

04

How to read an estradiol result

Start with the test method and reason for testing. Then add the timing and related hormone results.

Fits the setting

Within the method-specific interval for the stated question and timing

The result fits the expected range for the test question and timing. It may not answer a different question about cycle symptoms, PMDD, the pituitary gland, or ovarian function.

Check the method

Near an assay limit or difficult to reconcile with timing and companion results

Check the method, detection limit, cycle day, hormone products, FSH, LH, hCG, prolactin, TSH, and reason for testing. A planned repeat or LC-MS/MS test may give a clearer answer.

Lower result

Lower than expected for the clinical setting

Possible reasons include cycle timing, ovarian insufficiency, hypothalamus or pituitary problems, postpartum or breastfeeding changes, menopause, medicines, or the test's lower limit.

Higher result

Higher than expected for the clinical setting

Possible reasons include cycle timing, pregnancy, fertility treatment, estrogen use, body composition after menopause, ovarian activity, or a less common condition that makes estrogen. Check the setting before changing treatment.

Record when and how the estradiol sample was collected

A cycle-day result, a low-concentration result, and a treatment-monitoring result answer different questions. Check the method, detection limit, timing, medicines, and nearby hormones before calling estradiol deficient or excessive.

See research details

The table keeps assay examples, cycle research, menopause guidance, fertility limits, PMDD evidence, and cognition evidence in their own settings.

SourceA method-specific range is not a personal target ContextMayo's rapid immunoassay lists 10 to 40 pg/mL for adult males, 15 to 350 pg/mL before menopause, and below 10 pg/mL after menopause. The premenopausal interval is broad because estradiol changes across the cycle.

Use the interval printed on the report and the collection context. A range from another test method or clinic doesn't apply to this report.

SourceLow concentrations need the right assay ContextMayo states that its rapid immunoassay has a 25 pg/mL limit of quantitation and prefers LC-MS/MS for low concentrations in children, men, and postmenopausal women. CDC uses HPLC-MS/MS reference procedures and certifies estradiol methods against analytical performance criteria.

If the number is near the test's lower limit or doesn't fit the symptoms and other findings, ask whether you need a sensitive mass-spectrometry test.

SourceCycle phase changes the expected result ContextVerdonk 2019 measured 30 healthy cycling women daily and reported large, overlapping LC-MS/MS intervals across six cycle phases. Anckaert 2021 followed 85 apparently healthy women for one natural cycle and again found method- and phase-specific values.

Save the cycle day and the laboratory method. One broad range can't confirm ovulation or explain how symptoms change.

SourceA new 2026 postmenopausal research range is not a treatment target ContextCui 2026 harmonized primarily LC-MS/MS results from 7,206 postmenopausal women aged 38 to 100 who were not using estrogen. The overall 2.5th to 97.5th percentile was 1.1 to 18.2 pg/mL, with a median of 4.9 pg/mL; BMI, not chronological age, tracked with concentration.

This improves research comparability. It doesn't tell anyone whether to start, stop, or change hormone therapy, and it shouldn't replace the testing lab's range.

SourceMenopause is usually a clinical diagnosis ContextACOG says most women with typical perimenopause symptoms do not need hormone testing. Testing may be considered when changes happen before age 45 and especially before age 40. NICE also advises against using estradiol to diagnose menopause in otherwise healthy women aged 45 or older.

Use age, periods, symptoms, contraception, surgery, and other possible causes before ordering a random E2 value.

SourceEstradiol alone is not ovarian reserve ContextASRM recommends interpreting basal estradiol with FSH on cycle days 2 to 4 when ovarian-reserve testing is clinically appropriate. It says basal E2 alone should not screen diminished ovarian reserve, and ovarian-reserve markers are poor independent predictors of natural reproductive potential.

An estradiol test you order yourself can't predict egg quality, natural conception, or the time left to conceive.

SourcePMDD is not diagnosed by an E2 cutoff ContextWei 2025 studied 34 women with PMDD and 76 healthy participants during ovarian suppression and separate estradiol and progesterone addback. Symptoms emerged during addback in the PMDD group but not the healthy comparison group, supporting different sensitivity to hormonal change rather than a single abnormal estradiol level.

Use a daily symptom diary and clinical criteria for PMDD. Do not chase a serum estradiol target.

SourceA serum value does not measure cognition ContextGleason 2024 had cognitive follow-up data for 275 women about 10 years after the KEEPS treatment period and found no long-term cognitive benefit or harm from the randomized hormone-therapy allocation. Melville 2025 included 10 studies and 1,016,055 participants and found no significant association between menopausal hormone therapy and mild cognitive impairment or dementia.

Hormone therapy decisions belong to symptom, age, uterus, clot, cancer, bone, and cardiovascular context. One E2 value isn't enough to prescribe or reject treatment. Hormone therapy isn't for preventing dementia.

05

What you can do before changing hormones

One report isn't enough reason to raise or lower estradiol. Keep the timing clear and work on daily problems that may worsen the same symptoms.

Build one short timing record

For two cycles, mark bleeding, hot flashes, night sweats, sleep, headache, mood, pain, energy, focus, birth control, and medicine changes. Record ordinary days too.

Support sleep before blaming the number

Night sweats, pain, a waking baby, shift work, sleep apnea, alcohol, and medicines can hurt focus. Notice what woke you and how you felt the next day.

Eat regularly and avoid hormone diets

Eat regular balanced meals, get enough food, and drink regularly. Missing periods after too little food or too much exercise needs a proper review. Strict cleanses or hormone diets can make low energy worse.

Keep movement appropriate to your health

Walking, strength work, and weight-bearing activity can support sleep, mood, muscles, and bones when safe. Exercise isn't meant to force the number into a target range.

Bring the full hormone list

Bring photos or a list of every pill, patch, cream, gel, injection, pellet, fertility drug, birth control, DHEA product, and supplement. Add when and how you use each one.

What one estradiol result should not start

One estradiol result can't justify changing hormones, fertility medicines, contraception, or supplements. Get urgent help when pregnancy is possible and there is severe one-sided belly or pelvic pain, shoulder pain, dizziness, or fainting. Very heavy bleeding, chest pain, sudden trouble breathing, weakness, speech trouble, vision loss, or thoughts of self-harm are also urgent.

06

What to save from an estradiol result

Keep these together

  • Value, units, laboratory interval, assay method, detection or quantitation limit, collection date, and collection time
  • Reason for testing, cycle day, bleeding dates, pregnancy possibility, postpartum or breastfeeding context, and menopause context
  • Hormonal contraception, fertility medicines, estrogen, progesterone, testosterone, DHEA, cancer treatment, supplements, and last use time
  • FSH, LH, hCG, prolactin, TSH, testosterone, SHBG, ultrasound, symptoms, and the clinician's interpretation
  • The next decision, such as no repeat, a timed repeat, or a more sensitive LC-MS/MS method

Question for the visit

“Did this estradiol result answer the original question, or do the timing, assay, medicines, and companion results point to a repeat or a different workup?”
07

Sources for Estradiol

01
MedlinePlus, Estrogen Levels Test

Patient-facing reasons for testing, preparation, procedure, and interpretation context.

02
medlineplus.gov
03
Mayo Clinic Laboratories, Estradiol Rapid Immunoassay

Current method, preparation, adult intervals, quantitation limit, interference, and LC-MS/MS guidance.

04
CDC Hormone Standardization Program

Estradiol reference measurement and assay standardization.

05
www.cdc.gov
06
ACOG, hormone testing during perimenopause

When menopause symptoms usually do and do not need hormone testing.

07
NICE menopause quality statement

Why estradiol should not confirm typical menopause from age 45 onward.

08
ASRM ovarian reserve committee opinion

Cycle-day context, paired FSH, and fertility-prediction limits.

09
www.asrm.org
10
Endocrine Society hypothalamic amenorrhea guideline

Pregnancy exclusion, companion laboratory workup, and energy-availability context.

11
Verdonk et al., Clinica Chimica Acta, 2019

Traceable LC-MS/MS reference intervals across cycle phases, men, and postmenopausal women.

12
Anckaert et al., Practical Laboratory Medicine, 2021

Assay-specific estradiol, LH, and progesterone values across one natural cycle.

13
Cui et al., Journal of Clinical Endocrinology and Metabolism, 2026

Harmonized postmenopausal LC-MS/MS-based research reference range.

14
Wei et al., American Journal of Psychiatry, 2025

Experimental ovarian suppression and estradiol or progesterone addback in PMDD and healthy participants.

15
pubmed.ncbi.nlm.nih.gov
16
Gleason et al., PLOS Medicine, 2024

Long-term cognitive follow-up after randomized early menopausal hormone therapy.

17
Melville et al., Lancet Healthy Longevity, 2025

Systematic review and meta-analysis of hormone therapy, mild cognitive impairment, and dementia.

See each claim's sources